All treatments
Treatment
Gonadotropin-releasing hormone (GnRH) analogues clinical trials
2 indexed studies · 1 currently recruiting
- Active not recruitingPHASE1
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.
This study looks at new ways to treat prostate cancer that has spread. It uses special scans to find cancer cells and then delivers targeted radiation therapy to those cells, aiming to see how well it works and if it's safe.
For: Metastatic Neuroendocrine Prostate CancerUnited States · France · Germany - RecruitingPHASE1
A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study
This study looks at a new drug, AAA617, for men with advanced prostate cancer that has spread. We want to find the safest dose, check for side effects, and see how well it works when given for a longer time.
For: Metastatic Castration-Resistant Prostate CancerUnited States · Germany · Netherlands